Process Development

ProBioGen, Heidelberg Pharma Ink ATAC Agreement

ProBioGen is conducting cell line development, process development and GMP manufacturing of the mAb intermediates of Heidelberg’s ATAC molecules for cancer.

10.22.20

Breaking News | cGMP Manufacture | Formulation Development | Industry News | Process Development

Thomas Lee Partners, Frazier Healthcare Acquires Adare Pharmaceuticals

Includes Adare’s CDMO, pharmaceutical technology and microbiome businesses; will rebrand as Adare Pharma Solutions.

Contract Pharma Staff 09.30.20

Samsung Biologics Inks Service Pact with Panolos Bioscience

Will provide cell line development, process development, and clinical material manufacturing for PB101, an Fc-fusion protein to treat solid tumors.

Contract Pharma Staff 09.17.20

Faes Farma Chooses Syrris Asia to Develop Continuous Flow Processes

Acquired a Syrris Asia system in early 2018 with the aim of developing a new synthetic pathway for an existing API.

Contract Pharma Staff 09.08.20

Breaking News | Process Development | Promotions & Moves

Romanco Appoints Joint Managing Director of Romanco Innojet

Michael Van den Bossche brings two decades of experience.

Contract Pharma Staff 08.04.20

Bioanalytical Services | Breaking News | Industry News | Process Development

Lonza Expands Particle Engineering Services

Expands jet milling and spray dry processing for development at U.S. and European sites and enhances specialized processing capabilities.

Contract Pharma Staff 07.01.20

Biologics, Proteins, Vaccines | Breaking News | Clinical Trial Materials | Drug Development | Process Development

Arranta Bio Expands Microbiome Capacity at CoE

Adds additional early-clinical GMP capacity for microbiome process development and early clinical supply at Gainesville, FL site.

Contract Pharma Staff 05.28.20

Samsung Biologics, PharmAbcine Enter Antibody Pact

To develop and manufacture PMC-402, a next-gen therapeutic antibody candidate to treat oncology and neovascular disorders

Contract Pharma Staff 04.06.20

Bio News | Breaking News | cGMP Manufacture | Process Development

Immunogenesis, ProBioGen Enter Large-Scale Mfg. Pact

To provide cell line development, process development and GMP manufacture of Immunogenesis’ lead immuno-oncology candidate

03.25.20

Indapta, Lonza Form Immuno-oncology Partnership

Lonza to provide process development, clinical manufacturing and regulatory support for IND filing.

01.13.20

Breaking News | cGMP Manufacture | Drug Development | Industry News | Process Development

Alcami to Expand Charleston Ops

$17 million investment will add 6,000 sq.-ft., substantially augmenting capacity for sterile drug product development and manufacturing

12.19.19

Analytical Services | Process Development

Samsung Biologics

Samsung BioLogics is a full service provider of Quality driven cGMP contract manufacturing for the global biopharmaceutical industry. Our facilities are flexibly designed for cost effective production of monoclonal and recombinant drug substance and…

I.Chan Hwang, General Manager 12.13.19

APIs | Process Development | Validation

Rommelag CMO

Rommelag CMO provides you with quick and easy access to BFS technology without having to invest in either the mandatory GMP environment that goes with it or the specialists required to operate and maintain the machines. What we offer is the whole spe…

Andreas Haeussner, Director Marketing 12.09.19

Chemistry | Drug Development | Formulation Development | Process Development

Dalton Pharma Services

Dalton is a Health Canada approved, FDA registered, cGMP contract service provider of integrated chemistry, drug development and manufacturing services to the pharmaceutical and biotechnology industries. We accelerate drug development programs by int…

Sneha Subrahmanyam, Marketing Specialist 10.25.19

Avid Bioservices Completes Lab Expansion

Strengthens process development capabilities

10.08.19

cGMP Manufacture | Clinical Trial Materials | Industry News | Process Development | R&D

IBBR Seeks RFPs for cGMP Biologics Manufacturing

Facility is also equipped to perform process development research, preclinical manufacturing for IND-enabling tox studies, Point of Concept studies

08.19.19

Industry News | Process Development

Cambrex Expands Process Development at Edinburgh Facility

Doubles current footprint to 15,000 sq. ft., adding lab space to accommodate 40 more scientists

07.30.19

Bio News | Breaking News | Facilities | Industry News | Process Development

Sekisui Invests $1.9M in Microbial Biopharma CDMO Business

New BioProcess Innovation Center in UK will be operational by the end of 2019

05.16.19

Bio News | Biologics, Proteins, Vaccines | cGMP Manufacture | Industry News | Process Development

Biotechpharma Expands Manufacturing Capacity

Invests more than €50 million to further expanded fermentation capacity to 5,000 L

04.16.19

APIs | Process Development

MilliporeSigma

The journey from molecule to approved biologic is long, costly, complex, and risky - yet carries immense potential. At MilliporeSigma, we seek to understand the goals you have for your drug and then provide the solutions that will help you overcome y…

Silke Oligschlaeger, Marketing Communication Partner 04.16.19